Microglial NLRP3 Inflammasome Induces Excitatory Synaptic Loss Through IL-1β-Enriched Microvesicle Release:

Carolina A Moraes1, Eugenio D Hottz1,2, Débora Dos Santos Ornellas3

  • 1Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, RJ, Brazil.

Molecular Neurobiology
|October 24, 2022
PubMed

Insights

Microglial NLRP3 inflammasome activation in sepsis drives the release of IL-1β-enriched microvesicles, causing synaptic dysfunction and neuronal damage. Inhibiting this pathway may protect cognitive function during severe infections.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Sepsis-associated encephalopathy involves microglial activation and synaptic loss.
  • The upstream signals and mechanisms of microglial dysfunction in sepsis are not fully understood.

Purpose of the Study:

  • To investigate the role of the NLRP3 inflammasome in microglial activation and synaptic loss during sepsis.

Main Methods:

  • Utilized the cecal ligation and puncture (CLP) model in mice and primary microglia stimulated with LPS.
  • Assessed NLRP3 inflammasome components (NLRP3, ASC, caspase-1, IL-1β), mitochondrial ROS, and microvesicle (MV) release.
  • Examined the effects of pharmacological inhibition of NLRP3, caspase-1, and ROS on neuronal cultures.

Main Results:

  • CLP induced NLRP3 inflammasome component expression in septic mouse brains, particularly in hippocampal microglia.
  • LPS-stimulated microglia showed increased mitochondrial ROS, NLRP3 complex recruitment, and IL-1β release.
  • Microglial NLRP3 activation mediated caspase-1-dependent release of IL-1β-enriched MVs, which caused neurite suppression and synaptic loss in neurons.

Conclusions:

  • Microglial NLRP3 inflammasome activation is a key mechanism driving IL-1β-enriched MV release in sepsis.
  • This pathway contributes to synaptic impairment and neuronal damage, suggesting a therapeutic target for sepsis-induced encephalopathy.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...